Abstract
No single regulatory or governance strategy may be called upon that would singularly fulfill the actualization and promise of nanotechnology(ies) in terms of its universal societal adoption and acceptance. Instead, the obstacles and pitfalls that could derail its potential are scattered and varied, appearing in a multitude of disparate problem spaces and disciplines. The latter underlies the motivation behind this book. Acknowledging the multidisciplined character of nanotechnology, this book examines the core disciplines where the most troublesome issues are expected to appear (Part 1) and accordingly focuses on viable remedies (Part 2).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Ultrafine particles are less than 100 nm by definition.
Bibliography
Dawson, K. A., Salvati, A., & Lynch, I. (2009). Nanotoxicology: Nanoparticles reconstruct lipids. Nature Nanotechnology, 4(2), 84–85.
Han, S., Lee, J., Ahn, K., Kim, Y., Kim, J., Lee, J., … Yu, I. (2015). Size-dependent clearance of gold nanoparticles from lungs of Sprague–Dawley rats after short-term inhalation exposure. Archives of Toxicology, 89(7), 1083–1094. doi: 10.1007/s00204-014-1292-9.
Hussein, T., Hämeri, K., Aalto, P. P., Paatero, P., & Kulmala, M. (2005). Modal structure and spatial–temporal variations of urban and suburban aerosols in Helsinki—Finland. Atmospheric Environment, 39(9), 1655–1668. Retrieved from http://dx.doi.org/10.1016/j.atmosenv.2004.11.031
Klopffer, W., Curran, M. A., Frankl, P., Heijungs, R., Kohler, R., & Olsen, S. (2007). Nanotechnology and life cycle assessment. Washington, DC.
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012). Oral exposure to polystyrene nanoparticles affects iron absorption. Nature Nanotechnology, 7(4), 264–271. Retrieved from http://www.nature.com/nnano/journal/v7/n4/abs/nnano.2012.3.html#supplementary-information
Reijnders, L. (2007). Biological effects of nanoparticles used as glidants in powders. Powder Technology, 175(3), 142–145. Retrieved from http://dx.doi.org/10.1016/j.powtec.2007.02.002
Roduner, E. (2006). Size matters: Why nanomaterials are different. Chemical Society Reviews, 35(7), 583–592.
Salsburg, D., & Heath, A. (1981). When science progresses and bureaucracies lag: The case of cancer research. The Public Interest, 65, 30–39.
Yokel, R. A., Au, T. C., MacPhail, R., Hardas, S. S., Butterfield, D. A., Sultana, R., … Grulke, E. A. (2012). Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats. Toxicological Sciences, 127(1), 256–268. doi: 10.1093/toxsci/kfs067.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
McAlea, E.M., Murphy, F., Mullins, M. (2016). Introduction. In: Murphy, F., McAlea, E., Mullins, M. (eds) Managing Risk in Nanotechnology. Innovation, Technology, and Knowledge Management. Springer, Cham. https://doi.org/10.1007/978-3-319-32392-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-32392-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32390-9
Online ISBN: 978-3-319-32392-3
eBook Packages: Business and ManagementBusiness and Management (R0)